Related Experiment Video
Updated: Aug 16, 2026

High-throughput Measurement of Plasma Membrane Resealing Efficiency in Mammalian Cells
Published on: January 7, 2019
Protective effect of membrane cofactor protein against complement-dependent injury
Dong Xu1, Shou-jian Huang, Jin-qun Wang
1Department of Pharmacology, Sun Yat-Sen Medical College of Sun Yat-Sen University, Guangzhou 510080, China.
Aim:
To evaluate the protective role of membrane cofactor protein (MCP, CD46) on complement-dependent injury.
Methods:
MCP was separated by ion exchange chromatography on a DEAE sephadex A-50 column from pig erythrocyte ghosts. Its protective effect was tested in models such as cobra venom factor (CVF)-induced platelet metamorphosis and aggregation, human serum-induced injury in isolated working guinea pig heart and reverse passive Arthus reaction.
Results:
MCP inhibited CVF-induced platelet metamorphosis with an IC50 of 56.7 mg/L+/-2.6 mg/L, and prevented injury induced by activated complement in isolated working guinea pig hearts. In the rat model of reverse Arthus reaction, MCP relieved the skin lesions induced by immune complexes.
Conclusion:
MCP has a protective effect against complement-dependent injury.
Insights
Membrane cofactor protein (MCP, CD46) demonstrates a protective role against complement-dependent injury. Studies show MCP inhibits platelet damage and prevents tissue injury in various experimental models.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Complement-dependent injury is implicated in various pathological conditions.
- Membrane cofactor protein (MCP, CD46) is a complement regulatory protein.
Purpose of the Study:
- To evaluate the protective role of membrane cofactor protein (MCP, CD46) against complement-mediated damage.
Main Methods:
- MCP was isolated using ion exchange chromatography.
- Protective effects were assessed using models of cobra venom factor (CVF)-induced platelet activation, human serum-induced cardiac injury, and reverse passive Arthus reaction.
Main Results:
- MCP inhibited CVF-induced platelet metamorphosis with an IC50 of 56.7 mg/L.
- MCP prevented complement-induced injury in isolated working guinea pig hearts.
- MCP administration reduced skin lesions in a rat model of reverse Arthus reaction.
Conclusions:
- Membrane cofactor protein (MCP, CD46) exhibits a significant protective effect against complement-dependent injury.
- MCP demonstrates therapeutic potential in conditions involving complement activation.
More Related Videos
Related Concept Videos
Complement System
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Mechanisms of Membrane Domain Formation
Another mechanism for membrane domain formation involves membrane proteins interacting with cytoskeletal...
Hypersensitivity Reactions: Cytolytic Reactions
Cofactors and Coenzymes
Cofactors and Coenzymes
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...

